Myriad Genetics Inc SEC filings MYGN
Myriad Genetics Inc has 1,000 filings in SEC EDGAR's recent list, going back to Aug 31, 2015. Its latest annual report, Form ARS, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 6, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 4, 2026 | — |
| S-8 | Employee stock plan registration | Jun 4, 2026 | — |
| 424B3 | Prospectus | Mar 4, 2026 | — |
| S-3 | Shelf registration | Feb 24, 2026 | — |
| S-8 | Employee stock plan registration | Jun 5, 2025 | — |
| S-8 | Employee stock plan registration | May 1, 2025 | — |
| 424B5 | Prospectus supplement | Nov 13, 2023 | — |
| 424B5 | Prospectus supplement | Nov 8, 2023 | — |
| S-3ASR | Automatic shelf registration | Nov 8, 2023 | — |
| S-8 | Employee stock plan registration | Jun 1, 2023 | — |
| S-8 | Employee stock plan registration | Jun 6, 2022 | — |
| S-8 | Employee stock plan registration | Mar 16, 2021 | — |
| S-8 | Employee stock plan registration | Aug 14, 2020 | — |
| S-8 | Employee stock plan registration | Feb 7, 2020 | — |
| S-8 | Employee stock plan registration | Feb 8, 2019 | — |
| S-3ASR | Automatic shelf registration | Aug 1, 2018 | — |
| S-8 | Employee stock plan registration | Feb 7, 2018 | — |
| S-8 | Employee stock plan registration | Feb 8, 2017 | — |
| S-8 | Employee stock plan registration | Feb 3, 2016 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- MYGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Salt Lake City, UT
- SEC filer status
- Accelerated filer
- SEC CIK
- 899923
- Former names
- MYRIAD GENETICS INC (until Nov 6, 2026)
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Alpha Teknova, Inc. TKNO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.